Synthesis of new 4-methyl-2-(4-pyridyl)-1,2,3,4-tetrahydroquinolines as potent antifungal compounds

Journal of the Brazilian Chemical Society

Volumn 21, Issue 1, 2010, Pages 105-111

  Vargas Méndez, Leonor Y ^a   Zacchinob, Susana A ^b   Kouznetsov, Vladimir V ^c  

^a UNIVERSIDAD SANTO TOMÁS   (Colombia)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^c UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

Author keywords

2 (4 pyridyl) 1,2,3,4 tetrahydroquinolines; Antifungal activity; Homoallylamines

Indexed keywords

EID: 77951864388     PISSN: 01035053     EISSN: 16784790     Source Type: Journal    
DOI: 10.1590/s0103-50532010000100016     Document Type: Article

References (17)

1. Kleemann, A.; Engel, J.; Pharmaceutical Substances, Thieme: New York, 1999.
2. Kuznetsov, V. V.; Andreeva, E. I.; Prostakov, N. S.; Khim. Farm. Zh. 1995, 29, 61.
3. (CA, 1996, 124:48.290a).
4. Urbina, J. M. G.; Cortés, J. C.; Palma, A.; López, S. N.; Zacchino, S. A.; Enriz, D. R.; Ribas, J. C.; Kouznetsov, V.; Bioorg. Med. Chem. 2000, 8, 691.
5. Vargas Méndez, L. Y.; Castelli, M. V.; Kouznetsov, V. V.; Urbina, G. J. M.; López, S. N.; Sortino, M.; Enriz, R. D.; Ribas, J. C.; Zacchino, S. A.; Bioorg. Med. Chem. 2003, 11, 155.
6. Suvire, D. F.; Sortino, M.; Kouznetsov, V. V.; Vargas Méndez, L. Y.; Zacchino, S. A.; Mora Cruz, U.; Enriz, R. D.; Bioorg. Med. Chem. 2006, 14, 1851.
7. Kouznetsov, V. V.; Vargas Méndez, L. Y.; Sortino, M.; Vásquez, Y.; Gupta, M. P.; Freile, M.; Enriz, R. D.; Zacchino, S. A.; Bioorg. Med. Chem. 2008, 16, 794.
8. Vargas Méndez, L.Y.; Kouznetsov, V.; Heterocycl. Commun. 2002, 8, 583.
9. Vargas Méndez, L. Y.; Kouznetsov, V.; Stashenko, E.; Bahsas, A.; Amaro-Luis, J.; Heterocycl. Commun. 2001, 7, 323.
10. Kouznetsov, V. V.; Vargas Méndez, L. Y.; Synthesis 2008, 491.
11. Mikaya, A. I.; Lantsetov, S. V.; Kuznetsov, V. V.; Varlamov, A. V.; Prostakov, N. S.; Org. Mass Spectrom. 1991, 26, 763.
12. Clinical and Laboratory Standards Institute (CLSI, formerly National Committee for Clinical and Laboratory Standards NCCLS); Method M27-A2, 2nd ed, Wayne, ed.; NCCLS: Pennsylvania, 2002, Vol.22 (15), pp. 1-29.
13. Clinical and Laboratory Standards Institute (CLSI, formerly National Committee for Clinical and Laboratory Standards NCCLS); Method M-38A, 2nd ed, Wayne, ed.; NCCLS: Pennsylvania, 2002, Vol.22 (16), pp. 1-27.
14. Morgan, J.; Wannemuehler, K.; Marr, K.; Hadley, S.; Kontoyiannis, D.; Walsh, T.; Fridkin, S.; Pappas, P.; Warnock, D.; Med. Mycol. Suppl. 2005, 43, s49.
15. Maertens, J.; Raad, I.; Petrikkos, G.; Boogaerts, M.; Selleslag, D.; Petersen, F.; Sable, C.; Kartsonis, N.; Ngai, A.; Taylor, A.; Patterson, T.; Denning, D.; Walsh, T.J.; Clin. Infectious Diseases 2004, 39, 1563.
16. Weitzman, I.; Summerbell, R.; Clin. Microbiol. Rev. 1995, 8, 240.
17. Ablordeppey, S.; Fan, P.; Ablordeppey, J.; Mardenborough, L.; Curr. Med. Chem. 1999, 6, 1151.